Clinical trial
Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage…
NCT01554397 · University of California, San Diego, Other · Completed
Key facts
| NCT number | NCT01554397 |
|---|---|
| Title | Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer |
| Official title | Phase II/III Clinical Trial of Intensity Modulated Radiation Therapy With Concurrent Cisplatin for Stage I-IVA Cervical Carcinoma |
| Lead sponsor | University of California, San Diego, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Cervical Cancer |
| Intervention type | Drug, Radiation |
| Interventions | PET-guided Bone Marrow-Sparing Intensity Modulated Radiation Therapy (IMRT), Cisplatin, IMRT |
| Enrollment | 101 |
| Start date | Oct 13, 2011 |
| Primary completion | Jun 1, 2021 |
| Completion | Jan 1, 2022 |
| First posted | Mar 15, 2012 |
| Last update posted | Nov 29, 2024 |
| Countries | China, Czechia, India, Poland, Thailand, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: